Recombinant Ursus arctos Corticosteroid-binding globulin (Serpina6)

Shipped with Ice Packs
In Stock

Description

Molecular Characterization

Corticosteroid-binding globulin (CBG), encoded by the SERPINA6 gene, belongs to the serine protease inhibitor (serpin) superfamily. Key features include:

  • Molecular weight: ~50-55 kDa (glycosylated form)

  • Steroid-binding capacity: Single high-affinity site for cortisol and progesterone

  • Structural domains: Conserved serpin architecture with reactive center loop (RCL) critical for protease interaction

In Ursus arctos, the protein would likely share >80% sequence homology with human CBG based on mammalian serpin conservation patterns .

Biosynthesis and Recombinant Production

Recombinant CBG is typically produced using prokaryotic (E. coli) or eukaryotic (yeast) systems:

Production ParameterE. coli SystemYeast System
HostEscherichia coliSaccharomyces cerevisiae
GlycosylationAbsentPresent (native-like)
Purity>90% >95%
Functional ActivityRetains steroid bindingFull native conformation

Prokaryotic systems yield higher quantities, while eukaryotic systems preserve post-translational modifications critical for steroid-binding kinetics .

Steroid-Binding Specificity

Comparative studies of avian and mammalian CBGs reveal conserved ligand preferences:

SteroidBinding Affinity (IC₅₀ nM)
Cortisol1.7–4.2
Corticosterone4.0–4.2
Progesterone1.6–2.0
Dexamethasone2.4–3.7
Testosterone18.5–20.8

This pattern suggests Ursus arctos CBG would preferentially bind glucocorticoids over sex steroids, consistent with its role in stress response modulation .

Clinical and Physiological Relevance

CBG deficiency in humans (caused by SERPINA6 mutations) demonstrates:

  • 80–90% reduction in cortisol-binding capacity

  • Compensatory hypocortisolism despite normal free cortisol levels

  • Symptoms: Chronic fatigue, hypotension (30% of cases)

In Ursus arctos, seasonal variations in CBG expression likely modulate hibernation-related metabolic changes, though direct evidence remains lacking.

Pathogen Interaction Mechanisms

CBG serves as a protease-sensitive regulator of steroid bioavailability:

  • Pseudomonas aeruginosa elastase cleaves CBG's RCL, reducing cortisol binding by >90% within 2 hours

  • This mechanism is conserved across vertebrates, suggesting bears would show similar vulnerability during infections

Research Gaps and Future Directions

  1. No crystallographic data exists for Ursidae family CBGs

  2. Species-specific glycosylation patterns remain uncharacterized

  3. Hibernation physiology studies could clarify CBG's role in bear metabolic adaptation

Product Specs

Form
Lyophilized powder. We will ship the format we have in stock. If you have special format requirements, please note them when ordering.
Lead Time
Delivery times vary by purchase method and location. Consult your local distributor for specific delivery times. All proteins are shipped with blue ice packs by default. Contact us in advance for dry ice shipping (extra fees apply).
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer ingredients, storage temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us, and we will prioritize its development.
Synonyms
Serpina6; Cbg; Corticosteroid-binding globulin; CBG; Serpin A6; Transcortin
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
23-405
Protein Length
Full Length of Mature Protein
Purity
>85% (SDS-PAGE)
Species
Ursus arctos (Brown bear) (Grizzly bear)
Target Names
Serpina6
Target Protein Sequence
KDPDTDVS PRTPHRDLAP NNVDFAFILY RHLVASLPGK NVFISPVSIS MALAMLSLGA RGYTRVQLLQ GLGFNLTKLS EAEIHQGFRH LRHLFEKESD TMLEMAMGNA LFLDRNLELL ESFLADTKHY YEAEALAADF KDGAGASRQI NEYIKNKTQG KIVDLVSKLD SSAMLILVNY IFFKGTWEHP FDPESTRQEN FYVNKTTVVR VPMMFQSGTI KYLHDRVLPC QLVQLEYLGN GTVFFVLPEE GKMDTVIAAL SRDTIQRWSE SLTTGQVNLY VPRVVISGAY DLRAILGDMG IADLFDKEAD FSGITREAPL KLSKVVHKAV LQLDEKGLEA ATCPRVMLEG ASEPLTFRFD RPFVLMIFDH FSWSSLFLGK VVNPN
Uniprot No.

Target Background

Function
Corticosteroid-binding globulin (Serpina6) is the major transport protein for glucocorticoids and progestins in the blood of most vertebrates.
Protein Families
Serpin family
Subcellular Location
Secreted.

Q&A

What is Ursus arctos Corticosteroid-binding globulin and what is its primary function?

Corticosteroid-binding globulin (CBG), encoded by the SERPINA6 gene, is a transport protein that regulates the bioavailability of glucocorticoids and progesterone in the blood. In brown bears (Ursus arctos), CBG levels increase markedly during hibernation, suggesting this protein plays a key regulatory role in hibernation physiology by modulating sex steroid bioavailability . Like human CBG, ursine CBG is a homodimeric glycoprotein capable of binding steroids with high affinity. The protein contains a single steroid binding site with varying affinities for different steroid hormones, with approximately 80-90% of circulating cortisol typically bound to CBG in mammals . The CBG-bound cortisol is biologically inactive, while the unbound cortisol represents the active form, meaning that CBG directly regulates the proportion of active hormone available to tissues .

How does ursine CBG compare structurally and functionally to human CBG?

  • Expression efficiency: Ursine CBG shows markedly lower secretion levels compared to human CBG, resulting in a 10-fold difference in purified protein yield when expressed in the same insect cell-based expression system .

  • Steroid binding affinity: The dissociation constants for dihydrotestosterone (DHT) were determined to be 0.21 ± 0.04 nm for human CBG and 1.32 ± 0.10 nm for ursine CBG, confirming a significantly lower affinity of ursine CBG for this steroid. A similar reduced affinity pattern was observed for most steroids tested .

  • Thermal stability response: In the presence of DHT, the thermal stability of ursine and human CBG increased by 5.4°C and 9.5°C, respectively, further supporting differences in binding affinity .

These structural and functional differences may reflect adaptations related to the unique physiological requirements of bears, particularly during hibernation when CBG levels increase dramatically.

What expression systems are most effective for producing recombinant ursine CBG?

An insect cell-based expression system has been successfully established for recombinant full-length ursine CBG production . This system allows for proper post-translational modifications, particularly glycosylation, which is critical for CBG function. When selecting an expression system, researchers should consider:

  • Post-translational modification requirements: CBG is a glycosylated protein, making eukaryotic expression systems preferable over prokaryotic systems.

  • Yield considerations: Ursine CBG has demonstrated significantly lower secretion levels compared to human CBG in insect cells, with a 10-fold difference in purified protein yield . Therefore, optimization of expression conditions or exploration of alternative eukaryotic systems (such as HEK293 cells, which have been used successfully for human SERPINA6 ) may be necessary to improve yield.

  • Purification strategy: Recombinant CBG is typically produced with affinity tags (such as His-tags) to facilitate purification while maintaining protein integrity and function .

When designing expression constructs, inclusion of the native signal sequence or an appropriate alternative secretion signal is essential for proper folding and secretion.

What methodological approaches are recommended for assessing steroid binding properties of recombinant ursine CBG?

Several complementary methods can be employed to characterize steroid binding properties:

  • Radioligand binding assays: Using tritium-labeled steroids such as [³H]DHT to determine dissociation constants. This approach has revealed dissociation constants of 0.21 ± 0.04 nm for human and 1.32 ± 0.10 nm for ursine SHBG with DHT .

  • Competitive binding assays: These assays can determine relative binding affinities for various steroids by measuring displacement of a labeled reference steroid.

  • Thermal shift assays: The increase in thermal stability upon ligand binding provides an indication of binding affinity. For example, thermal stability of ursine and human CBG increased by 5.4°C and 9.5°C, respectively, in the presence of DHT .

  • Structural analysis: Techniques such as X-ray crystallography can reveal atomic interactions responsible for differential binding affinities. Crystal structures, such as the 2.5 Å structure of human CBG complexed with progesterone, have provided insights into why progesterone has lower affinity compared to corticosteroids .

When conducting these studies, it is critical to control experimental conditions (pH, temperature, salt concentration) as these can significantly impact binding properties.

How does the reactive center loop (RCL) cleavage affect the function of ursine CBG compared to other species?

The reactive center loop (RCL) cleavage reveals important species-specific differences in CBG function:

What role might ursine CBG play in hibernation physiology?

The marked increase in CBG levels during hibernation in brown bears suggests important regulatory functions in hibernation physiology . Several hypotheses can be investigated:

  • Hormone sequestration: Elevated CBG may serve to quench sex steroid bioavailability during hibernation, potentially redirecting metabolic resources away from reproductive functions .

  • Controlled hormone release: The lower binding affinity of ursine CBG compared to human CBG might allow for a more dynamic regulation of hormone availability during different phases of hibernation.

  • Metabolic regulation: CBG may influence metabolic adaptations during hibernation by controlling the availability of glucocorticoids, which are key regulators of energy metabolism.

To investigate these hypotheses, researchers could:

  • Compare CBG levels and binding affinities across different phases of hibernation

  • Analyze expression patterns of CBG and steroid receptors in various tissues during hibernation

  • Develop in vitro models to study how temperature fluctuations affect CBG-steroid interactions

  • Investigate potential interactions between CBG and other hibernation-related proteins

What are the methodological considerations for thermal stability analysis of recombinant ursine CBG?

Thermal stability analysis provides valuable insights into protein structure-function relationships and ligand interactions. Key methodological considerations include:

  • Technique selection:

    • Circular dichroism (CD) spectroscopy can monitor protein unfolding by detecting changes in secondary structure

    • Differential scanning calorimetry (DSC) provides thermodynamic parameters of protein unfolding

    • Fluorescence-based thermal shift assays offer high-throughput screening capabilities

  • Experimental parameters:

    • Heating rate should be consistent (typically 1°C/min) across all samples

    • Protein concentration should be optimized (too high may cause aggregation)

    • Buffer composition can significantly impact thermal stability

  • Comparative analysis:

    • For ursine CBG, thermal unfolding showed a single unfolding temperature of ~58°C, similar to human CBG

    • The presence of ligands (e.g., DHT) increased thermal stability by 5.4°C for ursine CBG and 9.5°C for human CBG

    • These differences reflect variation in binding affinity and should be correlated with binding constants determined by other methods

  • Data interpretation:

    • Changes in thermal stability upon ligand binding (ΔTm) correlate with binding affinity

    • Multiple transitions may indicate domain-specific unfolding or presence of multiple conformational states

    • Irreversible unfolding may complicate thermodynamic analysis

What genetic variants of SERPINA6 have been identified across species and how might they impact function?

Genetic variation in the SERPINA6 gene has been associated with altered CBG levels and function across species:

  • Human studies have identified several variants:

    • The rs11621961 SNP in the SERPINA6 gene has been significantly associated with total cortisol and CBG levels in genome-wide association studies

    • Additional SNPs in the gene (rs941601, rs11622665) have shown associations with CBG levels

  • Cross-species comparisons:

    • Comparative sequence analysis could reveal evolutionary adaptations in bears and other hibernating mammals

    • Identifying hibernation-specific variants might provide insights into CBG's role during this physiological state

  • Functional consequences of variants:

    • Alterations in steroid binding affinity

    • Changes in susceptibility to proteolytic cleavage

    • Differences in glycosylation patterns affecting half-life or tissue distribution

For ursine CBG research, targeted sequencing of the SERPINA6 gene in different bear populations, particularly comparing hibernating and non-hibernating individuals, could reveal functionally important genetic variants and their potential adaptive significance.

How can researchers effectively compare structural and functional properties of CBG across different species?

Effective cross-species comparison requires a structured approach:

  • Expression system standardization:

    • Using identical expression systems for all species variants minimizes system-specific effects

    • The insect cell-based expression system established for recombinant full-length ursine and human CBG provides a good model

  • Comparative binding studies:

    • Create a standardized panel of steroid ligands for testing across species

    • Include physiologically relevant steroids for each species

    • Present data in comparative format:

SteroidHuman CBG Kd (nM)Ursine CBG Kd (nM)Affinity Ratio (Human:Ursine)
DHT0.21 ± 0.041.32 ± 0.106.3
Cortisol[Value][Value][Ratio]
Progesterone[Value][Value][Ratio]

What are common challenges in producing and purifying functional recombinant ursine CBG?

Researchers may encounter several challenges when working with recombinant ursine CBG:

  • Low expression yield: Ursine CBG shows markedly lower secretion levels compared to human CBG, resulting in a 10-fold difference in purified protein yield . To address this:

    • Optimize codon usage for the expression system

    • Test different signal sequences to improve secretion

    • Evaluate alternative eukaryotic expression systems

  • Protein stability issues:

    • Recombinant CBG may be sensitive to freeze-thaw cycles; aliquoting is recommended to avoid repeated freezing/thawing

    • Storage recommendations include maintaining lyophilized protein at -20°C and reconstituted protein at 4°C

  • Glycosylation heterogeneity:

    • Different expression systems produce varying glycosylation patterns

    • Consider enzymatic deglycosylation for specific applications requiring homogeneous preparations

  • Functional verification:

    • Validate proper folding using circular dichroism

    • Confirm steroid binding activity using multiple complementary assays

    • Compare thermal stability profiles to published values (~58°C for ursine CBG)

  • Purification challenges:

    • Optimize purification protocols to minimize degradation

    • Consider including protease inhibitors throughout the purification process

    • Monitor RCL integrity, as spontaneous cleavage could affect functional studies

How can researchers investigate the relationship between hibernation physiology and ursine CBG function?

Investigating the relationship between hibernation and ursine CBG function requires integrating in vivo studies with in vitro analyses:

  • Seasonal sampling approach:

    • Collect blood samples from bears across the annual cycle (pre-hibernation, hibernation, arousal, active period)

    • Measure CBG levels, binding capacity, and steroid hormone profiles

    • Correlate changes with physiological parameters (body temperature, metabolic rate)

  • Temperature-dependent studies:

    • Assess steroid binding properties of recombinant ursine CBG at different temperatures relevant to hibernation

    • Compare thermal stability and conformational changes between hibernation (low) and active (normal) body temperatures

    • Investigate if temperature shifts alter the susceptibility of the RCL to proteolytic cleavage

  • Tissue-specific expression analysis:

    • Examine SERPINA6 expression in liver and other tissues during different hibernation phases

    • Investigate potential extra-hepatic production of CBG during hibernation

    • Analyze regulators of CBG expression in the context of hibernation signals

  • Comparative hibernator studies:

    • Compare CBG properties across multiple hibernating species to identify common adaptations

    • Include closely related non-hibernating species as controls

  • Functional studies:

    • Develop cell-based assays to test how CBG from hibernating bears affects cellular responses to hormones

    • Investigate the interaction between CBG and hormone receptors under hibernation-like conditions

By integrating these approaches, researchers can develop a comprehensive understanding of how ursine CBG adaptations support the unique physiological demands of hibernation.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.